Utility of low- frequency piezoelectric thromboelastography (LPTEG) for comparison of mono- and combined antithrombotic therapy results in patients with morbid obesity

Tarabrin, O.; Sukhonos, R.; Suslov, O.; Volodychev, D.; Vorotyntsev, S.; Tarabrin, P.

dc.contributor.author	Tarabrin, O.
dc.contributor.author	Sukhonos, R.
dc.contributor.author	Suslov, O.
dc.contributor.author	Volodychev, D.
dc.contributor.author	Vorotyntsev, S.
dc.contributor.author	Tarabrin, P.
dc.date.accessioned	2020-06-15T09:19:34Z
dc.date.available	2020-06-15T09:19:34Z
dc.date.issued	2019
dc.identifier.citation	Utility of low- frequency piezoelectric thromboelastography (LPTEG) for comparison of mono- and combined antithrombotic therapy results in patients with morbid obesity / O. Tarabrin, R. Sukhonos, O. Suslov et al. // Critical Care. 2019. N 23. P. 145–147.	uk_UA
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7342
dc.description.abstract	Patients with morbid obesity (MO) have a high risk of thromboembolic events. In patients with a BMI >35, the hypercoagulable state is due to impairment of all parts of the blood coagulation as well as anticoagulation mechanisms by obesity. Combined therapy of thromboembolic complications in patients with obesity Sodium Enoxaparin sodium and Pentoxifylline is more effective than Enoxaparin sodium monotherapy because it affects all parts of the hemostatic system.	uk_UA
dc.language.iso	en	uk_UA
dc.subject	utility of low- frequency piezoelectric thromboelastography (LPTEG)	uk_UA
dc.subject	mono- and combined antithrombotic therapy results	uk_UA
dc.subject	morbid obesity	uk_UA
dc.subject	combined therapy	uk_UA
dc.title	Utility of low- frequency piezoelectric thromboelastography (LPTEG) for comparison of mono- and combined antithrombotic therapy results in patients with morbid obesity	uk_UA
dc.type	Article	uk_UA